The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company
25 October 2011 - 4:52AM
Business Wire
Former United States Securities and Exchange Commission attorney
Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the
securities litigation firm of Powers Taylor, LLP announce that the
firms are investigating legal claims against the officers and Board
of Directors of K-V Pharmaceutical Company (“KV Pharmaceutical” or
“KV-A”) (NYSE: KV-A) (NYSE: KV-B) related to potential securities
violations by KV Pharmaceutical between February 14, 2011 and April
4, 2011 (the “Class Period”).
If you are an affected investor and you want to learn more about
the lawsuit or join the action, contact Patrick Powers at Powers
Taylor, LLP, toll free (877) 728-9607, via e-mail at
patrick@powerstaylor.com, or Willie Briscoe at The Briscoe Law
Firm, PLLC, (214) 706-9314, or via email at
WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you.
It has been alleged that during the Class Period, KV
Pharmaceutical and certain of its officers and directors made
materially false and misleading statements or failed to disclose
material information related to the company’s business and
operations in violation of the Securities Exchange Act of 1934.
Specifically, the complaint alleges that defendants misrepresented
that the Food and Drug Administration (FDA) had granted KV
Pharmaceutical the exclusive distribution rights over "Makena," a
drug used to prevent miscarriages, and that the FDA would enforce
those rights by preventing KV Pharmaceutical’s competitors from
distributing generic formulations of the drug. The complaint
further alleges that defendants failed to disclose that the drug’s
$1,500 price actually would reduce the availability of Makena to
low-income and other at-risk groups. It’s alleged that the
defendants’ false statements cause KV Pharmaceutical’s stock to
trade at artificially inflated prices during the Class Period.
The Briscoe Law Firm, PLLC is a full service business
litigation, commercial transaction, and public advocacy firm with
more than 20 years of experience in complex litigation and
transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that
handles a variety of complex business litigation matters, including
claims of investor and stockholder fraud, shareholder oppression,
shareholder derivative suits, and security class actions.
K V Pharma CL A (NYSE:KVA)
Historical Stock Chart
From Nov 2024 to Dec 2024
K V Pharma CL A (NYSE:KVA)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about K V Pharma CL A (New York Stock Exchange): 0 recent articles
More Powers Taylor, LLP News Articles